MetaCap

CareDx (CDNA) vs RadNet (RDNT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CareDx (CDNA) has outperformed RadNet (RDNT) over the past year, gaining 307.5% versus a loss of 16.0%. Over five years, RDNT leads with a +159.6% price change compared with +65.2% for CDNA. RadNet is the larger company by market cap ($5.49 billion vs $3.68 billion), about 1.5 times the size, while CareDx is growing revenue faster (+13.8% vs +11.5%).

On valuation, CareDx trades at a lower forward P/E (44.7x vs 66.4x for RadNet). RadNet converts more of its revenue into profit, with a net margin of -0.9% versus -5.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDNA+307.45%RDNT-16.01%
+438%+189%-60%
Nov 21, 20251 yearNov 20, 2026
CDNA+62.75%RDNT+146.33%
+209%+53%-103%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDNA versus RDNT key metrics
MetricCDNARDNT
Share price$70.00$69.71
Market cap$3.68B$5.49B
1-day change-2.67%+0.29%
YTD return+271.55%-2.30%
1-year return+307.45%-16.01%
5-year return+65.21%+159.63%
P/E ratio (TTM)29.54—
Forward P/E44.7566.39
EPS (TTM)$2.37$-0.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$379.81M$2.04B
Revenue growth (YoY)+13.79%+11.51%
Net income (latest FY)$-21.35M$-18.65M
Operating margin-8.10%3.04%
Net margin-5.62%-0.91%
52-week high$90.87$85.84
52-week low$15.56$50.82
Distance from 52-week high-22.97%-18.79%
Analyst consensusbuystrong_buy
Avg. price target upside+34.90%+39.15%
Average volume1.30M688.04K
Shares outstanding52.54M78.77M
Employees76112,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CDNA has outperformed RDNT by 323.5 percentage points over the past year.

About CareDx

CDNA stock →

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Health Care · Medical Specialities · 761 employees

About RadNet

RDNT stock →

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health.

Health Care · Medical Specialities · 12,000 employees

CDNA vs RDNT FAQ

Which is bigger, CareDx or RadNet?

RadNet (RDNT) is larger, with a market capitalization of $5.49B compared with $3.68B for CareDx (CDNA).

Which stock has performed better over the past year, CDNA or RDNT?

CDNA returned +307.45% over the past 12 months, compared with -16.01% for RDNT (price return, excluding dividends). Past performance does not predict future results.

Are CareDx and RadNet in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons